Overview
The DIA–MHRA Global Summit brings together global leaders across the healthcare innovation ecosystem to explore how innovation can reach patients faster.
Developed in partnership with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), this inaugural gathering will showcase how the UK enables innovation across the full pathway — from early development and clinical investigation, through regulation and evidence generation, to real-world adoption in healthcare systems.
At a time when artificial intelligence and digital technologies are transforming healthcare, this summit will focus on how regulation, data, and system collaboration can accelerate safe, effective patient access to innovation.
An exciting programme is currently in development — and registration is now open. Stay tuned for further details to be announced soon.

Program Committee
-
Virginia Acha AVP, Science and Regulatory Policy
Merck & Co., Inc., United Kingdom -
Julian Beach, MBA Interim Executive Director, Healthcare Quality and Access
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Sunera Awan Head RA UKI
Bayer, United Kingdom -
Alison Cave Chief Safety Officer
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Jacob George Chief Medical & Scientific Officer
MHRA, United Kingdom -
Saira Ghafur Lead for Digital Health - Institute of Global Health Innovation
Imperial College London, United Kingdom -
Ed Middleton Interim Director of Strategy
Medicines and Healthcare products Regulatory Agency, United Kingdom -
Hannie De Munnik, MSc Executive Director EUCAN Regulatory Affairs
Astrazeneca BV, Netherlands -
Dan O'Connor Executive Director Regulatory
The Association of the British Pharmaceutical Industry (ABPI), United Kingdom -
Magda Papadaki Vice President, Regulatory & Translational innovation
Flagship Pioneering, United States -
James Pound Interim Executive Director, Innovation and Compliance
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom -
Jane Wall Managing Director
BioIndustry Association (BIA), United Kingdom -
Gina Weston Head of Regulatory Affairs, UK & Ireland, Europe and Regional Liaison
GlaxoSmithKline (GSK), United Kingdom
Have an account?
